Skip Navigation Links.
Skip Navigation LinksHome | Drug Discovery | Discovery & Profiling | Discovery ADME/DMPK
Discovery ADME/DMPK

MDS Pharma Services offers a line of discovery ADME screening assays designed for researchers to rank order their compound according to physiochemical, metabolic, and CYP inhibition properties. Researchers use our data to identify compounds that exhibit more or less desirable ADME and PK properties for their intended target. Early in vivo discovery PK studies in rodents provide unequivocal evidence of drug exposure. Early in vivo testing is the first opportunity to establish proof of concept and confidently elevate a compound from hit to lead.

In Vitro ADME Testing
Our well known profiling and screening services are routinely used to determined specificity and selectivity of new chemical entities for hit compound ranking and lead selection. One of the key steps after initial screening is early in vitro ADME testing.

MDS Pharma Services offers a discovery range of in vitro ADME screening services to predict in vivo behavior of molecules. These services include:

Click on appropriate assay name for additional assay information. Click on any column header to sort list by that column.
Catalog #▲  Assay NameFamily Name
710020 CYP450 Inhibition 5 in 1 Discovery In Vitro ADME
710010 LogD7.4 Discovery In Vitro ADME
710040 Metabolic Soft Spot Analysis Discovery In Vitro ADME
710000 Metabolic Stability Discovery In Vitro ADME
710030 Solubility Screen Discovery In Vitro ADME

In Vivo Discovery PK Testing
MDS Pharma Services offers a broad range of preclinical DMPK services to assist pharmaceutical and biotechnology companies in preclinical development. Our services are built on basic study designs including:

Click on appropriate assay name for additional assay information. Click on any column header to sort list by that column.